|Bid||0.00 x 800|
|Ask||0.00 x 1000|
|Day's Range||11.85 - 12.80|
|52 Week Range||5.12 - 15.30|
|Beta (3Y Monthly)||4.09|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Ryan McQueeney discusses President Trump's latest comments on the trade war and the impending vote of confidence facing U.K. Prime Minister Theresa May. He also recaps earnings results from the retail sector. Later, he highlights three cannabis stocks to watch as the farm bill passes.
CORAL GABLES, FL / ACCESSWIRE / December 12, 2018 / If you thought that marijuana stocks were done for the year, you may be finding yourself at a loss for words after the latest industry moves. Not only has the Farm Bill and New York state legalization taken a place on the "breaking marijuana stock news" list this week, so has interest from new investment firms. Tiki Barber, former NFL running back and chief business development officer and co-founder of Grove Group Management, and Kevin Shin, CEO and co-founder were interviewed recently about the topic.
HENDERSON, NV / ACCESSWIRE / December 12, 2018 / Senate Majority Leader, Mitch McConnell, got the Twitter space buzzing when he said, "With today's signature, my provision to legalize industrial hemp ...
Investors need to pay close attention to Cronos Group (CRON) stock based on the movements in the options market lately.
HENDERSON NV / ACCESSWIRE / December 12, 2018 / Cannabis indoor grow operations accounts for 1% of electricity consumption in the US. Here are a few companies you should look at to capitalize on this fact. ...
Investorideas.com, a leading investor news resource covering real estate and cannabis stocks, releases a snapshot looking at the synergistic opportunity for both sectors. As the emerging cannabis market explodes with increased legalization across North American markets, Metrospaces, Inc. (OTC:MSPC) Company Executive President Mr. Oscar Brito highlights the considerable market opportunities in real estate that many investors may have overlooked.
Shares of Canopy Growth (CGC) were up more than 6% in late afternoon trading Tuesday, as investors expressed optimism about the Senate's hemp legalization bill and management's comments about interest from institutional investors.
Altria Group (NYSE:MO) is joining the mega-cap firms eager to hedge against a potential decline in their home business. On Dec. 7, the firm said it would invest a $1.8 billion stake in Cronos Group (NASDAQ:CRON). Meanwhile, Constellation Brands (NYSE:STZ) bought Canopy Growth (NYSE:CGC) at the beginning of this year.
Most recently, the big focus for Canadian cannabis companies, in particular, has been on the pharmacy space. Canada's biggest retailer now provides medical cannabis. Although it's been known for months, Loblaw Co. Ltd.'s Shoppers Drug Mart pharmacy has been granted a license to sell medical marijuana online.
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the growing opportunity in the sector with the expected imminent passing of the US 2018 Farm Bill. Cabot Wealth said last week in an article, What the Farm Bill Means for Cannabis Stocks, “If the Farm Bill passes with hemp legalization intact, it could herald boom times for the CBD industry, with giant retail players like Walgreens and CVS and Walmart becoming the biggest retailers.
The Zacks Analyst Blog Highlights: Altria, Cronos, Constellation, Canopy Growth and ETFMG Alternative Harvest
Despite broader market turmoil, the cannabis sector is starting to heat up again thanks to M&A activity. First it was Canopy Growth (NYSE:CGC), then Cronos (NASDAQ:CRON), and I think the next target is going to be Aphria (NYSE:APHA) stock. Now, everyone is again bidding up pot stocks in an attempt to find the next M&A target, which leads us to Aphria.
MedMen is on the forefront of the modern cannabis industry. Yahoo Finance's Seana Smith, Adam Shapiro , and Adam Bierman, Medmen CEO discuss.